Gilect 1 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose for patients taking levodopa is 0.5mg once daily. If well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to certain patients. It should not be taken if there is an allergy to its active ingredient or other components. Caution is required if the patient is currently taking or has recently stopped taking other MAO inhibitors or certain natural medicines, as it may be dangerous to combine with this drug. In particular, patients taking or having recently discontinued medications such as pethidine, tramadol, or dextromethorphan should not use this drug. This medication should not be given to patients with moderate to severe liver dysfunction. Various adverse effects may occur when taking this medication, including headache, dizziness, dermatitis, nausea, insomnia, and arthralgia, which have been commonly reported. Additionally, mental symptoms such as depression or hallucinations may occur, so changes in symptoms should be closely monitored. This medication can cause side effects such as movement disorders or hypotension, especially when taken with other Parkinson's disease treatments, so more caution is needed. Impulse control disorders may arise, so patients and their caretakers should be aware of compulsive behaviors or pathological gambling tendencies and regularly check the patient's condition. For patients with impaired liver function, blood levels of this drug may increase, so liver function should be assessed before administration and should be used with caution. Drowsiness or sudden sleep may occur during driving or operating machinery, so hazardous activities should be avoided in case such symptoms are present. This drug has a high potential for interactions with other medications, so it is essential to consult with a healthcare professional, especially when combined with other MAO inhibitors, antidepressants, sympathomimetics, or certain analgesics. The safety of this drug has not been established in pregnant or breastfeeding women, so it should be used cautiously. It is advisable not to use it in children under 18, as safety and efficacy have not been confirmed. In the case of overdose, serious side effects can occur, and appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of the reach of children and stored in a tightly sealed container at temperatures between 1 degree and 25 degrees Celsius.

• Influenza
• skin cancer
• leukopenia
• allergy
• decreased appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is a cool place between 1 degree and 25 degrees Celsius.

Appearance

Round white or nearly white tablets

Package unit

PTP - 30 tablets/box [(10 tablets/PTP X 3)]